Although the expression of IGFBP2 is controlled by epigenetic DNA methylation in glioma patients 42, we find no significant different methylation intensity of IGFBP2 and TIMP1 genes between old and young LGG patients (Figure 4B). This evidence concerns the gene IGFBP2 and central nervous system cancer.